The WBBA is hosting a forum on translational medicine on Oct. 12, honing in on the process of turning biological discoveries into drugs and/or medical devices that can help patients better, faster, and cheaper. Speakers include Tom Clement, the CEO of Aqueduct; Tom Fritz, the CEO of Inland Northwest Health Services; Mike Gallatin, the former president of Calistoga Pharmaceuticals; Jeffrey Herz, the founder and president of Algomedix; and Gary Jones, the chief medical officer of C3 Research Associates. For more information on how to register, click here.